Chronic Urticaria: A Review of the Basics and New Drugs

June 29, 2026

Despite its prevalence, chronic spontaneous urticaria remains a condition that is frequently undertreated and misunderstood. Listen as Brad Glick, DO, MPH, FAAD and Walter Liszewski, MD, FAAD discuss practical strategies for recognizing and managing chronic spontaneous urticaria.

Summary

Availability:

On-Demand

Expires on Jun 29, 2029

Credit Offered:

0.5 CME Credit

Recommended

Question of the Week Self-Assessment - 2026

13.25 CME

March JAAD: Joint Position Statement on Routine Testing for Latent Tuberculosis Infection Prior to and During Treatment of Psoriasis Patients

June 22, 2026

Advances in psoriasis treatment have raised important questions about whether historical monitoring practices remain necessary for newer biologic agents. Join Sanna Ronkainen, MD and Andy Blauvelt, MD as they discuss the data informing updated recommendations on latent tuberculosis testing for patients treated with IL-17 and IL-23 inhibitors.

0.5 CME

Untangling the mystery of central centrifugal cicatricial alopecia: What new research insights have taught us (July JAAD)

September 1, 2025

Once believed to be derived from poor hairstyling practices, Josee Smith, MD and Crystal Aguh, MD, FAAD discuss the complex mystery of central centrifugal cicatricial alopecia, or CCCA. Learn more about new treatments and proper diagnosis to provide you patients with a better outcome from this scarring condition.

0.5 CME

Granulomatous Diseases: A Review and Update for 2026 and Beyond

June 15, 2026

Granulomatous diseases are often associated with complex diagnostic and therapeutic challenges, but emerging evidence is helping clinicians navigate these conditions with greater confidence. Listen as Jenna Koblinski, MD and Misha Rosenbach, MD, FAAD as they review current approaches to diagnosis, systemic evaluation, and treatment of granulomatous disorders.

0.5 CME

Hair Disorders Made Easier

April 20, 2026

Hair loss disorders are increasingly encountered in dermatologic practice and can be difficult to evaluate and treat. Join Maryanne Makredes Senna, MD, FAAD and Neal Bhatia, MD, FAAD as they discuss how practical diagnostic strategies can simplify the management of alopecia.

0.5 CME

Hidradenitis Suppurativa

March 30, 2026

A growing range of therapeutic options is influencing care for patients with hidradenitis suppurativa. Listen as Jennifer Hsiao, MD, FAAD and Jacquelyn Dosal, MD, FAAD examine how individualized, multimodal approaches can support more effective disease control.

0.5 CME

Opportunistic Infections and Drug Rashes Oh My: Managing the Cutaneous Complications of Solid Organ Transplantation

June 8, 2026

Solid organ transplant recipients face unique dermatologic challenges due to chronic immunosuppression and increased susceptibility to infection. Join Stephanie Gallitano, MD, FAAD and Lilia Correa-Selm, MD, FAAD as they discuss how thoughtful management can help navigate complex cutaneous complications in this population.

0.5 CME

The Evolving Toolbox for Treating Difficult Warts

November 3, 2025

Despite their common condition, warts are often stubborn to the most routine care. On this episode, Peter Friedman, MD, FAAD and Hillary Johnson-Jahangir, MD, PhD, FAAD highlight how today’s therapeutic toolbox is giving dermatologists fresh options for treatment.

0.5 CME

Vitiligo

September 8, 2025

Recent developments in treatment for vitiligo are redefining what long-term management and re-pigmentation can look like. Listen as David Rosmarin, MD, FAAD and Olayemi Sokumbi, MD, FAAD discuss how these new therapies are reshaping long-term outcomes and expectations for patients and physicians alike.

0.5 CME

High-Yield Updates on Management of Bread N' Butter Dermatologic Diseases

August 4, 2025

New treatments raise excitement in the field of dermatology, but they also lead to learning curves to optimize patient care. Listen as Erin Wei, MD, FAAD and Shawna Flanagan, MD, FAAD discusses High-Yield Updates on Management of Bread N’ Butter Dermatologic Diseases including the latest therapies and safety profiles, chemoprevention, and clinical pathology pearls.

0.5 CME